Liraglutide and semaglutide reduce alcohol intake, cutting it by nearly two-thirds within four months of treatment.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

Patients taking liraglutide or semaglutide for weight loss report their alcohol intake dropping with the pounds-by as much as ...

The study showed that Glucagon-like peptide-1 (GLP-1) analogues — drugs developed to treat obesity — likely curb alcohol ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Medications such as liraglutide or semaglutide taken for weight loss also have the potential to reduce alcohol consumption by ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

Weight loss drugs could “revolutionise the treatment of alcohol use disorder” by “effortlessly” slashing the amount that ...

Study finds average alcohol consumption among participants fell from 11.3 units a week to 4.3 units a week after four months ...